Therapeutic Drug Monitoring Market - Global Industry Analysis

Therapeutic Drug Monitoring Market by Product Split (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors , Clinical Chemistry Analyzers), By Technology Split (Immunoassays., Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassays, Other Immunoassays, Chromatography-MS, LC-MS, GC-MS), By Class of drug Split (Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs), By End User Split (Hospital Laboratories, Commercial & Private Laboratories, Other End Users) and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2021 – 2028

Published Date: 26-May-2022 Category: Healthcare Report Format : PDF Pages: 188 Report Code: ZMR-3497 Status : Published

The global Therapeutic Drug Monitoring market was worth around USD 1,692.90 billion in 2021 and is estimated to grow to about USD 2854.83 billion by 2028, with a compound annual growth rate (CAGR) of approximately 9.10 percent over the forecast period. therapeutic drug monitoring icd 10

Description

Industry Prospective:

The global Therapeutic Drug Monitoring market was worth around USD 1,692.90 billion in 2021 and is estimated to grow to about USD 2854.83 billion by 2028, with a compound annual growth rate (CAGR) of approximately 9.10 percent over the forecast period. The report analyzes the Therapeutic Drug Monitoring market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Therapeutic Drug Monitoring market.

Therapeutic Drug Monitoring Market: Overview

Therapeutic drug monitoring is a test that involves measuring different medications in the bloodstream to ensure that the correct amount of treatment is being provided. It determines whether the quantity is sufficient to be useful while avoiding any serious reactions or adverse effects. Anti-arrhythmics, antibiotics, anti-epileptics, and psychotropic medications all require monitoring to guarantee their safety and effectiveness.

 One of the primary factors driving the market's growth is the increase in demand for hospitals and medical care facilities around the world.The growing importance of (TDM) in organ transplant procedures, as well as a growing inclination for precision medicine, are propelling the market forward. The market is also influenced by the increased focus on drug research and development activities, as well as the widespread use of drug monitoring tests across many therapeutic disciplines.

COVID-19 Impact:

Globally, COVID-19 has had a global impact on the pharmaceutical, diagnostics and medical industries, especially the therapeutic drug monitoring sector.Closed manufacturing facilities impacted supply chains and limited recruitment; nonetheless, restarting clinical trials in the COVID-19 pandemic recovery phase 2021 will be difficult because to restricted access at trial sites. As a result, any further delays in clinical trials will have an impact on the overall therapeutic drug monitoring market's growth in 2021. As a result of the sick population, medical supplies are in higher demand. Respiratory support equipment, such as an atomizer, a life-support machine, an oxygen generator, and a monitor, are among the most regularly utilised medical devices in primary clinical care. The need for medical supplies from both healthcare professionals and the general population is increasing as the number of COVID-19 cases increases around the world. By keeping a consistent supply of personal protective equipment on the market, manufacturers of these items can profit from the increased demand for medical supplies.

Global Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market: Growth Drivers

Increasing preference for precision medicine of the market growth

 Precision medicine is a growing field of disease treatment and prevention that takes into account individual differences in genes, surroundings, and lifestyles. Precision medicine is picking treatments that are completely suited to a patient's ailment and medical history. Oncology has experienced the most development, despite the fact that this technique is extending into all disease areas. Cancer patients are being treated with a combination of medications based on studies of the patient's factors such as systems biology, tumour analysis, and gene expression data in the absence and presence of pharmacological disruption. This method, which is now being tried in a variety of situations, intends to transform pharmacotherapy in oncology and other disease areas. TDM has the potential to make a significant contribution to the advancement of this unique approach to patient care.

Therapeutic Drug Monitoring Market: Restraints

 Operational barriers faced in conducting TDM tests of the market growth

Clinical laboratories across major markets are still changing. As a result, technicians have operational issues in procuring, storing, and transporting samples, particularly when using novel technologies like chemiluminescence immunoassays, HPLC, and multiplex flow immunoassays (MFI). To eliminate cross-contamination and maintain efficient time management, laboratory space must also be redesigned to match the requirements of conducting specialised immunoassay tests for pathogen identification. The cost of maintaining and operating modern immunoassay devices, especially those that can only handle a single sample type, is prohibitive..

Therapeutic Drug Monitoring Market: Opportunities

Increasing adoption in the treatment of autoimmune diseases of the market growth

 Anti-TNF-alpha biologics are used to treat autoimmune illnesses such rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) (IBD). The number of R&D initiatives focusing on the creation of biosimilars has expanded in recent years as healthcare expenses have risen and patents have expired. With the introduction of biosimilars to the market, there is a greater need to evaluate potential changes in biosimilar immunogenicity, as well as their safety and effectiveness characteristics when compared to their predecessors. TNF-alpha blockers like infliximab and adalimumab, for example, can both elicit immunogenicity reactions; researchers have speculated that their biosimilars medicines (CT-P13) may do the same. To provide optimal patient care, it is critical to develop methodologies for the TDM of biosimilar medications for autoimmune disorders..

Global Therapeutic Drug Monitoring Market: Segmentation

The global Therapeutic Drug Monitoring market is segregated based on product split, technology split, glass of drug split,end user split , and region.

The Therapeutic Drug Monitoring market is divided into Consumables, Equipment-Immunoassay Analyzers, Chromatography & MS Detectors, and Clinical Chemistry Analyzers based on the type of product. During the period of 2021 to 2028, the Consumables segment is expected to grow at the fastest CAGR. The demand for recurring purchases of kits and reagents, as well as the growing number of immunoassay tests performed around the world, are two important reasons driving the growth of this market..

By end user split, the market is divided into Hospital Laboratories, Commercial & Private Laboratories and Other End Users). Hospital Laboratories is having the largest share for the end uer split. Personalized medicine is propelling the therapeutic drug monitoring market forward, owing to rising desire for improved treatment outcomes with fewer medication side effects. TDM, for example, is widely used for anti-cancer drug monitoring, for which various oncology journals and societies, including the European Journal of Oncology, have published standard standards. Advanced treatment techniques such as pharmacogenomics, gene testing, and proteomics are also projected to drive market expansion. One of the primary factors driving the TDM market's growth is the rise of antimicrobial resistance.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Recent Developments

  • June 2021 - Implementing a personalised therapeutic drug monitoring (TDM) strategy at the time of infliximab beginning does not increase remission rates in patients with a variety of inflammatory disorders, according to study results presented at the EULAR 2020 E-Congress.
  • February 2019 - LabCorp, a prominent global life sciences firm, recently announced the addition of a new assay to its DoseASSURE therapeutic drug monitoring (TDM) platform. The novel Certolizumab Concentration and Anti-Certolizumab Antibody DoseASSURE CTZ assay aids physicians in tracking individual treatment response in patients taking Certolizumab, a biologic therapy used to treat inflammatory illnesses like rheumatoid arthritis and Crohn's disease.

Regional Landscape

North America is having the largest share because of its superior health care base, strong regional economies, and government emphasis on prevention and wellness. Increased per capita healthcare expenditures and the development of technologically advanced healthcare infrastructure are driving this industry forward. Furthermore, the region's focus has changed away from simple TDM tests and toward comprehensive testing in order to identify the gaps between prescribing the correct drug dosage and attaining the intended therapeutic outcome.

Competitive Landscape

Some of the main competitors dominating the global Therapeutic Drug Monitoring market include - Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Exagen Inc. (US), R-Biopharm AG (Germany), ApDia Group (Belgium), UTAK (US), Randox Laboratories Ltd. (Ireland), ARK Diagnostics, Inc. (US). BioTeZ Berlin-Buch GmbH (Germany), Eagle Biosciences, Inc. (US), Jasem Laboratory Systems and Solutions (Turkey), Aalto Scientific, Ltd. (US), Immundiagnostik AG (Germany), Sekisui Medical Co. Ltd. (Japan), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (UK), Chromsystems Instruments & Chemicals GmbH (Germany), and BÜHLMANN Laboratories (Switzerland).

Global Therapeutic Drug Monitoring market is segmented as follows:

By Product Split

  • Consumables
  • Equipment
  • Immunoassay Analyzers
  • Chromatography & MS Detectors
  • Clinical Chemistry Analyzers

By Technology Split

  • Immunoassays.
  • Chemiluminescence Immunoassays
  • Colorimetric Immunoassays
  • Fluorescence Immunoassays
  • Radioimmunoassays
  • Other Immunoassays
  • Chromatography-MS
  • LC-MS
  • GC-MS

By Class of drug Split

  • Antiepileptic Drugs
  • Antibiotic Drugs
  • Immunosuppressant Drugs
  • Antiarrhythmic Drugs
  • Bronchodilator Drugs
  • Psychoactive Drugs
  • Other Drugs

By End user Split

  • Hospital Laboratories
  • Commercial & Private Laboratories
  • Other End Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Therapeutic Drug Monitoring Market, (2022 - 2028) (USD Billion )
    • 2.2 Global Therapeutic Drug Monitoring Market : snapshot
  • Chapter 3. Global Therapeutic Drug Monitoring Market - Industry Analysis
    • 3.1 Therapeutic Drug Monitoring Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing preference for precision medicine of the market growth
    • 3.3 Market Restraints
      • 3.3.1. Operational barriers faced in conducting TDM tests of the market growth
    • 3.4 Market Opportunities
      • 3.4.1. Increasing adoption in the treatment of autoimmune diseases of the market growth
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product Split
      • 3.7.2 Market attractiveness analysis By Technology Split
      • 3.7.3 Market attractiveness analysis By Class of drug Split
      • 3.7.4 Market attractiveness analysis By End user Split
  • Chapter 4. Global Therapeutic Drug Monitoring Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Therapeutic Drug Monitoring Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Therapeutic Drug Monitoring Market - Product Split Analysis
    • 5.1 Global Therapeutic Drug Monitoring Market overview: By Product Split
      • 5.1.1 Global Therapeutic Drug Monitoring Market share, By Product Split, 2021 and 2028
    • 5.2 Consumables
      • 5.2.1 Global Therapeutic Drug Monitoring Market by Consumables, 2022 - 2028 (USD Billion )
    • 5.3 Equipment
      • 5.3.1 Global Therapeutic Drug Monitoring Market by Equipment, 2022 - 2028 (USD Billion )
    • 5.4 Immunoassay Analyzers
      • 5.4.1 Global Therapeutic Drug Monitoring Market by Immunoassay Analyzers, 2022 - 2028 (USD Billion )
    • 5.5 Chromatography & MS Detectors
      • 5.5.1 Global Therapeutic Drug Monitoring Market by Chromatography & MS Detectors, 2022 - 2028 (USD Billion )
    • 5.6 Clinical Chemistry Analyzers
      • 5.6.1 Global Therapeutic Drug Monitoring Market by Clinical Chemistry Analyzers, 2022 - 2028 (USD Billion )
  • Chapter 6. Global Therapeutic Drug Monitoring Market - Technology Split Analysis
    • 6.1 Global Therapeutic Drug Monitoring Market overview: By Technology Split
      • 6.1.1 Global Therapeutic Drug Monitoring Market share, By Technology Split, 2021 and 2028
    • 6.2 Immunoassays.
      • 6.2.1 Global Therapeutic Drug Monitoring Market by Immunoassays., 2022 - 2028 (USD Billion )
    • 6.3 Chemiluminescence Immunoassays
      • 6.3.1 Global Therapeutic Drug Monitoring Market by Chemiluminescence Immunoassays, 2022 - 2028 (USD Billion )
    • 6.4 Colorimetric Immunoassays
      • 6.4.1 Global Therapeutic Drug Monitoring Market by Colorimetric Immunoassays, 2022 - 2028 (USD Billion )
    • 6.5 Fluorescence Immunoassays
      • 6.5.1 Global Therapeutic Drug Monitoring Market by Fluorescence Immunoassays, 2022 - 2028 (USD Billion )
    • 6.6 Radioimmunoassays
      • 6.6.1 Global Therapeutic Drug Monitoring Market by Radioimmunoassays, 2022 - 2028 (USD Billion )
    • 6.7 Other Immunoassays
      • 6.7.1 Global Therapeutic Drug Monitoring Market by Other Immunoassays, 2022 - 2028 (USD Billion )
    • 6.8 Chromatography-MS
      • 6.8.1 Global Therapeutic Drug Monitoring Market by Chromatography-MS, 2022 - 2028 (USD Billion )
    • 6.9 LC-MS
      • 6.9.1 Global Therapeutic Drug Monitoring Market by LC-MS, 2022 - 2028 (USD Billion )
    • 6.10 GC-MS
      • 6.10.1 Global Therapeutic Drug Monitoring Market by GC-MS, 2022 - 2028 (USD Billion )
  • Chapter 7. Global Therapeutic Drug Monitoring Market - Class of drug Split Analysis
    • 7.1 Global Therapeutic Drug Monitoring Market overview: By Class of drug Split
      • 7.1.1 Global Therapeutic Drug Monitoring Market share, By Class of drug Split, 2021 and 2028
    • 7.2 Antiepileptic Drugs
      • 7.2.1 Global Therapeutic Drug Monitoring Market by Antiepileptic Drugs, 2022 - 2028 (USD Billion )
    • 7.3 Antibiotic Drugs
      • 7.3.1 Global Therapeutic Drug Monitoring Market by Antibiotic Drugs, 2022 - 2028 (USD Billion )
    • 7.4 Immunosuppressant Drugs
      • 7.4.1 Global Therapeutic Drug Monitoring Market by Immunosuppressant Drugs, 2022 - 2028 (USD Billion )
    • 7.5 Antiarrhythmic Drugs
      • 7.5.1 Global Therapeutic Drug Monitoring Market by Antiarrhythmic Drugs, 2022 - 2028 (USD Billion )
    • 7.6 Bronchodilator Drugs
      • 7.6.1 Global Therapeutic Drug Monitoring Market by Bronchodilator Drugs, 2022 - 2028 (USD Billion )
    • 7.7 Psychoactive Drugs
      • 7.7.1 Global Therapeutic Drug Monitoring Market by Psychoactive Drugs, 2022 - 2028 (USD Billion )
    • 7.8 Other Drugs
      • 7.8.1 Global Therapeutic Drug Monitoring Market by Other Drugs, 2022 - 2028 (USD Billion )
  • Chapter 8. Global Therapeutic Drug Monitoring Market - End user Split Analysis
    • 8.1 Global Therapeutic Drug Monitoring Market overview: By End user Split
      • 8.1.1 Global Therapeutic Drug Monitoring Market share, By End user Split, 2021 and 2028
    • 8.2 Hospital Laboratories
      • 8.2.1 Global Therapeutic Drug Monitoring Market by Hospital Laboratories, 2022 - 2028 (USD Billion )
    • 8.3 Commercial & Private Laboratories
      • 8.3.1 Global Therapeutic Drug Monitoring Market by Commercial & Private Laboratories, 2022 - 2028 (USD Billion )
    • 8.4 Other End Users
      • 8.4.1 Global Therapeutic Drug Monitoring Market by Other End Users, 2022 - 2028 (USD Billion )
  • Chapter 9. Therapeutic Drug Monitoring Market - Regional Analysis
    • 9.1 Global Therapeutic Drug Monitoring Market Regional Overview
    • 9.2 Global Therapeutic Drug Monitoring Market Share, by Region, 2021 & 2028 (USD Billion )
    • 9.3. North America
      • 9.3.1 North America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
        • 9.3.1.1 North America Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
    • 9.4 North America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
      • 9.4.1 North America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
    • 9.5 North America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
      • 9.5.1 North America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
    • 9.6 North America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
      • 9.6.1 North America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
    • 9.7 North America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
      • 9.7.1 North America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
    • 9.4. Europe
      • 9.4.2 Europe Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
        • 9.4.2.1 Europe Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
    • 9.4 Europe Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
      • 9.4.1 Europe Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
    • 9.5 Europe Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
      • 9.5.1 Europe Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
    • 9.6 Europe Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
      • 9.6.1 Europe Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
    • 9.7 Europe Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
      • 9.7.1 Europe Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
        • 9.5.3.1 Asia Pacific Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
    • 9.4 Asia Pacific Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
      • 9.4.1 Asia Pacific Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
    • 9.5 Asia Pacific Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
      • 9.5.1 Asia Pacific Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
    • 9.6 Asia Pacific Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
      • 9.6.1 Asia Pacific Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
    • 9.7 Asia Pacific Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
      • 9.7.1 Asia Pacific Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
    • 9.6. Latin America
      • 9.6.4 Latin America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
        • 9.6.4.1 Latin America Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
    • 9.4 Latin America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
      • 9.4.1 Latin America Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
    • 9.5 Latin America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
      • 9.5.1 Latin America Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
    • 9.6 Latin America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
      • 9.6.1 Latin America Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
    • 9.7 Latin America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
      • 9.7.1 Latin America Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
        • 9.7.5.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Country, 2022 - 2028 (USD Billion )
    • 9.4 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028
      • 9.4.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Product Split, 2022 - 2028 (USD Billion )
    • 9.5 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028
      • 9.5.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Technology Split, 2022 - 2028 (USD Billion )
    • 9.6 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028
      • 9.6.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by Class of drug Split, 2022 - 2028 (USD Billion )
    • 9.7 The Middle-East and Africa Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028
      • 9.7.1 The Middle-East and Africa Therapeutic Drug Monitoring Market, by End user Split, 2022 - 2028 (USD Billion )
  • Chapter 10. Company Profiles
    • 10.1 Abbott (US)
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Thermo Fisher Scientific (US)
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 F. Hoffmann-La Roche Ltd. (Switzerland)
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Siemens Healthineers AG (Germany)
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 Danaher Corporation (US)
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Bio-Rad Laboratories (US)
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 bioMérieux SA (France)
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Theradiag SA (France)
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Grifols S.A. (Spain)
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Exagen Inc. (US)
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 R-Biopharm AG (Germany)
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 ApDia Group (Belgium)
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments
    • 10.13 UTAK (US)
      • 10.13.1 Overview
      • 10.13.2 Financials
      • 10.13.3 Product Portfolio
      • 10.13.4 Business Strategy
      • 10.13.5 Recent Developments
    • 10.14 Randox Laboratories Ltd. (Ireland)
      • 10.14.1 Overview
      • 10.14.2 Financials
      • 10.14.3 Product Portfolio
      • 10.14.4 Business Strategy
      • 10.14.5 Recent Developments
    • 10.15 ARK Diagnostics
      • 10.15.1 Overview
      • 10.15.2 Financials
      • 10.15.3 Product Portfolio
      • 10.15.4 Business Strategy
      • 10.15.5 Recent Developments
    • 10.16 Inc. (US). BioTeZ Berlin-Buch GmbH (Germany)
      • 10.16.1 Overview
      • 10.16.2 Financials
      • 10.16.3 Product Portfolio
      • 10.16.4 Business Strategy
      • 10.16.5 Recent Developments
    • 10.17 Eagle Biosciences Inc. (US)
      • 10.17.1 Overview
      • 10.17.2 Financials
      • 10.17.3 Product Portfolio
      • 10.17.4 Business Strategy
      • 10.17.5 Recent Developments
    • 10.18 Jasem Laboratory Systems and Solutions (Turkey)
      • 10.18.1 Overview
      • 10.18.2 Financials
      • 10.18.3 Product Portfolio
      • 10.18.4 Business Strategy
      • 10.18.5 Recent Developments
    • 10.19 Aalto Scientific Ltd. (US)
      • 10.19.1 Overview
      • 10.19.2 Financials
      • 10.19.3 Product Portfolio
      • 10.19.4 Business Strategy
      • 10.19.5 Recent Developments
    • 10.20 Immundiagnostik AG (Germany)
      • 10.20.1 Overview
      • 10.20.2 Financials
      • 10.20.3 Product Portfolio
      • 10.20.4 Business Strategy
      • 10.20.5 Recent Developments
    • 10.21 Sekisui Medical Co. Ltd. (Japan)
      • 10.21.1 Overview
      • 10.21.2 Financials
      • 10.21.3 Product Portfolio
      • 10.21.4 Business Strategy
      • 10.21.5 Recent Developments
    • 10.22 DiaSystem Scandinavia AB (Sweden)
      • 10.22.1 Overview
      • 10.22.2 Financials
      • 10.22.3 Product Portfolio
      • 10.22.4 Business Strategy
      • 10.22.5 Recent Developments
    • 10.23 Cambridge Life Sciences Limited (UK)
      • 10.23.1 Overview
      • 10.23.2 Financials
      • 10.23.3 Product Portfolio
      • 10.23.4 Business Strategy
      • 10.23.5 Recent Developments
    • 10.24 Chromsystems Instruments & Chemicals GmbH (Germany)
      • 10.24.1 Overview
      • 10.24.2 Financials
      • 10.24.3 Product Portfolio
      • 10.24.4 Business Strategy
      • 10.24.5 Recent Developments
    • 10.25 BÜHLMANN Laboratories (Switzerland).
      • 10.25.1 Overview
      • 10.25.2 Financials
      • 10.25.3 Product Portfolio
      • 10.25.4 Business Strategy
      • 10.25.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
  • 4. Porter’s Five Forces Analysis
  • 5. Global Therapeutic Drug Monitoring Market attractiveness, By Product Split
  • 6. Global Therapeutic Drug Monitoring Market attractiveness, By Technology Split
  • 7. Global Therapeutic Drug Monitoring Market attractiveness, By Class of drug Split
  • 8. Global Therapeutic Drug Monitoring Market attractiveness, By End user Split
  • 9. Global Therapeutic Drug Monitoring Market share by Product Split, 2022 and 2028 (USD Billion )
  • 10. Global Therapeutic Drug Monitoring Market by Consumables, 2022 - 2028 (USD Billion )
  • 11. Global Therapeutic Drug Monitoring Market by Equipment, 2022 - 2028 (USD Billion )
  • 12. Global Therapeutic Drug Monitoring Market by Immunoassay Analyzers, 2022 - 2028 (USD Billion )
  • 13. Global Therapeutic Drug Monitoring Market by Chromatography & MS Detectors, 2022 - 2028 (USD Billion )
  • 14. Global Therapeutic Drug Monitoring Market by Clinical Chemistry Analyzers, 2022 - 2028 (USD Billion )
  • 15. Global Therapeutic Drug Monitoring Market share by Technology Split, 2022 and 2028 (USD Billion )
  • 16. Global Therapeutic Drug Monitoring Market by Immunoassays., 2022 - 2028 (USD Billion )
  • 17. Global Therapeutic Drug Monitoring Market by Chemiluminescence Immunoassays, 2022 - 2028 (USD Billion )
  • 18. Global Therapeutic Drug Monitoring Market by Colorimetric Immunoassays, 2022 - 2028 (USD Billion )
  • 19. Global Therapeutic Drug Monitoring Market by Fluorescence Immunoassays, 2022 - 2028 (USD Billion )
  • 20. Global Therapeutic Drug Monitoring Market by Radioimmunoassays, 2022 - 2028 (USD Billion )
  • 21. Global Therapeutic Drug Monitoring Market by Other Immunoassays, 2022 - 2028 (USD Billion )
  • 22. Global Therapeutic Drug Monitoring Market by Chromatography-MS, 2022 - 2028 (USD Billion )
  • 23. Global Therapeutic Drug Monitoring Market by LC-MS, 2022 - 2028 (USD Billion )
  • 24. Global Therapeutic Drug Monitoring Market by GC-MS, 2022 - 2028 (USD Billion )
  • 25. Global Therapeutic Drug Monitoring Market share by Class of drug Split, 2022 and 2028 (USD Billion )
  • 26. Global Therapeutic Drug Monitoring Market by Antiepileptic Drugs, 2022 - 2028 (USD Billion )
  • 27. Global Therapeutic Drug Monitoring Market by Antibiotic Drugs, 2022 - 2028 (USD Billion )
  • 28. Global Therapeutic Drug Monitoring Market by Immunosuppressant Drugs, 2022 - 2028 (USD Billion )
  • 29. Global Therapeutic Drug Monitoring Market by Antiarrhythmic Drugs, 2022 - 2028 (USD Billion )
  • 30. Global Therapeutic Drug Monitoring Market by Bronchodilator Drugs, 2022 - 2028 (USD Billion )
  • 31. Global Therapeutic Drug Monitoring Market by Psychoactive Drugs, 2022 - 2028 (USD Billion )
  • 32. Global Therapeutic Drug Monitoring Market by Other Drugs, 2022 - 2028 (USD Billion )
  • 33. Global Therapeutic Drug Monitoring Market share by End user Split, 2022 and 2028 (USD Billion )
  • 34. Global Therapeutic Drug Monitoring Market by Hospital Laboratories, 2022 - 2028 (USD Billion )
  • 35. Global Therapeutic Drug Monitoring Market by Commercial & Private Laboratories, 2022 - 2028 (USD Billion )
  • 36. Global Therapeutic Drug Monitoring Market by Other End Users, 2022 - 2028 (USD Billion )
  • 37. Global Therapeutic Drug Monitoring Market share, by Region, 2022 and 2028
  • 38. North America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
  • 39. Europe Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
  • 40. Asia Pacific Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
  • 41. Latin America Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )
  • 42. The Middle-East and Africa Therapeutic Drug Monitoring Market, 2022 - 2028 (USD Billion )

Table Of Tables

  • 1. Global Therapeutic Drug Monitoring Market: Snapshot
  • 2. Drivers of the Therapeutic Drug Monitoring Market: impact analysis
  • 3. North America Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 4. North America Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 5. North America Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 6. North America Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 7. U.S. Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 8. U.S. Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 9. U.S. Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 10. U.S. Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 11. Canada Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 12. Canada Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 13. Canada Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 14. Canada Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 15. Europe Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 16. Europe Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 17. Europe Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 18. Europe Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 19. Germany Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 20. Germany Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 21. Germany Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 22. Germany Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 23. France Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 24. France Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 25. France Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 26. France Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 27. U.K. Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 28. U.K. Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 29. U.K. Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 30. U.K. Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 31. Italy Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 32. Italy Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 33. Italy Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 34. Italy Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 35. Spain Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 36. Spain Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 37. Spain Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 38. Spain Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 39. Rest of Europe Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 40. Rest of Europe Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 41. Rest of Europe Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 42. Rest of Europe Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 43. Asia Pacific Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 44. Asia Pacific Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 45. Asia Pacific Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 46. Asia Pacific Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 47. China Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 48. China Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 49. China Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 50. China Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 51. Japan Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 52. Japan Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 53. Japan Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 54. Japan Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 55. India Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 56. India Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 57. India Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 58. India Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 59. South Korea Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 60. South Korea Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 61. South Korea Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 62. South Korea Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 63. South-East Asia Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 64. South-East Asia Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 65. South-East Asia Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 66. South-East Asia Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 67. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 68. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 69. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 70. Rest of Asia Pacific Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 71. Latin America Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 72. Latin America Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 73. Latin America Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 74. Latin America Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 75. Brazil Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 76. Brazil Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 77. Brazil Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 78. Brazil Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 79. Mexico Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 80. Mexico Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 81. Mexico Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 82. Mexico Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 83. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 84. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 85. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 86. Rest of Latin America Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 87. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 88. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 89. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 90. The Middle-East and Africa Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 91. GCC Countries Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 92. GCC Countries Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 93. GCC Countries Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 94. GCC Countries Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 95. South Africa Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 96. South Africa Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 97. South Africa Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 98. South Africa Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )
  • 99. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By Product Split, 2022 - 2028 (USD Billion )
  • 100. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By Technology Split, 2022 - 2028 (USD Billion )
  • 101. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By Class of drug Split, 2022 - 2028 (USD Billion )
  • 102. Rest of Middle-East Africa Therapeutic Drug Monitoring Market revenue, By End user Split, 2022 - 2028 (USD Billion )

Methodology

Free Analysis

Therapeutic drug monitoring(TDM)has several benefits for patients who are on regular medication or suffering from illnesses, infections, accidents, surgeries, and physical stresses. It involves regular measurement of medicines and drugs in order to maintain a constant concentration of medications in the bloodstream. These days therapeutic drug monitoring (TDM) has become a highly essential and vital method to avoid drug toxicity. Adverse drug reactions occur due to inaccurate dosage and, sometimes, lead to critical medical conditions and, in many cases, lead to death, if not managed properly. 

Growing demand for therapeutic drug monitoring around the world for organized disease treatment is the key driver for the global therapeutic drug monitoring market. In addition, the growing geriatric population and the rapid increase in the prevalence of cancer and diabetes are further expected to augment the growth of this market in the upcoming years. However, the high cost of therapeutic drug monitoring, strict government regulations, and lack of trained resources are the major factors restraining the growth of the therapeutic drug monitoring market. On the other hand, rapid technological advancements in therapeutics drug monitoring solutions are likely to offer prospective opportunities in the forecast timeframe.

Global Therapeutic Drug Monitoring Market

On the basis of product type, the market is segmented into equipment and consumables. Among these, the equipment segment was the highest revenue grosser in the year 2017.

On the basis of drug class, the market is segmented into antiarrhythmic drugs, antibiotic drugs, immunosuppressant drugs, bronchodilator drugs, psychoactive drug, antiepileptic drugs, and others.

The end-users in the therapeutic drug monitoring market are commercial/private labs, hospital labs, and others. The commercial/private companies dominated the market and accounted for the largest share in 2017. The growth of this segment is primarily credited to the growing awareness among people regarding the benefits of therapeutic drug monitoring. The hospital lab segment is projected to grow at the highest CAGR in the forecast span.

Based on geography, the global therapeutic drug monitoring market is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America was the leading region in terms of revenue generation in 2017. Europe was the second largest market followed by the Asia Pacific. The Asia Pacific therapeutic drug monitoring market was the fastest growing market in 2017 and is anticipated to grow at a significant pace in the following years. The growth in this region can be attributed to the rapid development of healthcare infrastructure and heightened corporate investments in the healthcare sector. The Middle East and African and Latin American regions are expected to experience moderate growth in the therapeutic drug monitoring market in the years to come. 

Some of the major players in the global therapeutic drug monitoring market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Siemens Healthcare, Bio-Rad Laboratories Inc., and Danaher Corporation, among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The therapeutic drug monitoring market is predicted to develop due to factors such as an increase in demand for better healthcare in the urban population, an increase in the number of organ transplant surgeries, and the use of therapeutic drug monitoring in traditional anticancer therapy.

According to the Market Research report, the global Therapeutic Drug Monitoring market was worth about 1692.90 (USD billion) in 2021 and is predicted to grow to around 2854.83 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 9.10 percent.

North America leads the global Therapeutic Drug Monitoring because of the region's technologically advanced healthcare infrastructure. Due to increased investments in the region, Asia-Pacific (APAC) is predicted to develop significantly during the forecast period of 2022 to 2029.

Some of the main competitors dominating the global Therapeutic Drug Monitoring market include - Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Exagen Inc. (US), R-Biopharm AG (Germany), ApDia Group (Belgium), UTAK (US), Randox Laboratories Ltd. (Ireland), ARK Diagnostics, Inc. (US). BioTeZ Berlin-Buch GmbH (Germany), Eagle Biosciences, Inc. (US), Jasem Laboratory Systems and Solutions (Turkey), Aalto Scientific, Ltd. (US), Immundiagnostik AG (Germany), Sekisui Medical Co. Ltd. (Japan), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (UK), Chromsystems Instruments & Chemicals GmbH (Germany), and BÜHLMANN Laboratories (Switzerland).

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed